Finance

Lists
Why is GTBP down 4.84%?
Dive Deeper
GTBP:NASDAQ
GT Biopharma Inc
$6.69
-4.84%
(-0.34) 1D
Oct 19, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GTBP...
Open
$7.17
High
$7.17
Low
$6.69
Mkt. cap
13.79M
Avg. vol.
136.10K
Volume
28.70K
52-wk high
$28.75
52-wk low
$4.91
EPS
-$35.41
Beta
0.86
Shares outstanding
2.06M
No. of employees
1
Open
$7.17
High
$7.17
Low
$6.69
Mkt. cap
13.79M
Avg. vol.
136.10K
Volume
28.70K
52-wk high
$28.75
52-wk low
$4.91
EPS
-$35.41
Beta
0.86
Shares outstanding
2.06M
No. of employees
1
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
13 hours ago
Understanding the Setup: (GTBP) and Scalable Risk
About GT Biopharma Inc
CEO-
Employees1
Founded1965
HeadquartersSan Francisco, California, United States
SectorBiotechnology
Websitegtbiopharma.com
Analyst ratings
Based on 1 analyst giving stock ratings to GTBP in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for GTBP in the last 3 months
Highest
Current $6.69
$3.00 (-55.16%)
Average
$3.00 (-55.16%)
Lowest
$3.00 (-55.16%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jonathan Aschoff
Roth MKM
Buy
Maintained
$3.00
-55.2%
08/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
634.00K
1.38M
413.00K
1.06M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.75M
4.22M
2.44M
3.46M
Operating expense
3.38M
5.60M
2.85M
4.51M
Total operating expenses
3.38M
5.60M
2.85M
4.51M
Operating income
-3.38M
-5.60M
-2.85M
-4.51M
Other non operating income
232.00K
-17.33M
11.00K
-
EBT including unusual items
-3.11M
-23.03M
-2.83M
-4.52M
EBT excluding unusual items
-3.11M
-23.03M
-2.83M
-4.52M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.11M
-23.03M
-2.83M
-4.52M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
36.00K
17.00K
67.00K
58.00K
Interest expense
-
-127.00K
-63.00K
-64.00K
Net interest expenses
36.00K
-110.00K
4.00K
-6.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps